Carr Patricia 4
4 · Jazz Pharmaceuticals plc · Filed Mar 11, 2025
Insider Transaction Report
Form 4
Carr Patricia
SVP, Chief Accounting Officer
Transactions
- Disposition to Issuer
Ordinary Shares
2025-03-07$138.23/sh−1,333$184,261→ 8,152 total - Sale
Ordinary Shares
2025-03-10$137.81/sh−1,140$157,103→ 7,012 total
Footnotes (1)
- [F1]Shares sold to satisfy tax obligations arising out of the vesting of previously granted restricted stock units.